Lloyd A. Rowland
2021
In 2021, Lloyd A. Rowland earned a total compensation of $1.4M as Senior Vice President, General Counsel, Chief Compliance Officer and Secretary at CytomX Therapeutics, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $171,288 |
|---|---|
| Option Awards | $667,492 |
| Salary | $417,778 |
| Stock Awards | $160,200 |
| Other | $5,000 |
| Total | $1,421,758 |
Rowland received $667.5K in option awards, accounting for 47% of the total pay in 2021.
Rowland also received $171.3K in non-equity incentive plan, $417.8K in salary, $160.2K in stock awards and $5K in other compensation.
Rankings
In 2021, Lloyd A. Rowland's compensation ranked 7,476th out of 12,415 executives tracked by ExecPay. In other words, Rowland earned more than 39.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,476 out of 12,415 | 40th |
Division Manufacturing | 3,290 out of 5,508 | 40th |
Major group Chemicals And Allied Products | 1,456 out of 2,378 | 39th |
Industry group Drugs | 1,297 out of 2,099 | 38th |
Industry Pharmaceutical Preparations | 954 out of 1,549 | 38th |
Source: SEC filing on April 27, 2022.
Rowland's colleagues
We found five more compensation records of executives who worked with Lloyd A. Rowland at CytomX Therapeutics in 2021.
2021
Sean McCarthy
CytomX Therapeutics
Chief Executive Officer
2021
Amy Peterson
CytomX Therapeutics
Chief Operating Officer
2021
Jeff Landau
CytomX Therapeutics
Senior Vice President and Chief Business Officer
2021
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
2021
Carlos Campoy
CytomX Therapeutics